ARTICLES BY THIS AUTHOR
- 3/28/2021
New York launches nation's first ‘vaccine passport’
The Excelsior Pass — which helps confirm a person's proof of vaccination or negative COVID-19 test results — is expected to be accepted at dozens of events, arts and entertainment venues in New York. - 3/28/2021
GSK, Vir seek emergency use OK for COVID-19 therapy
Earlier this month, GSK and Vir found that their experimental COVID treatment, VIR-7831, reduced the risk of hospitalization and deaths among patients by 85%, based on interim data from a study. - 3/28/2021
NeedyMeds' drug discount card exceeds $300M in savings
NeedyMeds has information on hundreds of programs that offer free medications to those who qualify. - 3/25/2021
Trial to study delivering AstraZeneca COVID-19 vaccine as a nasal spray
An AstraZeneca nasal spray trial could start as early as next week, according to a Financial Times report. - 3/25/2021
Aurobindo intros generic Gleevec
Imatinib mesylate tablets have a market value of roughly $324 million for the 12 months ended January 2021, according to IQVIA. - 3/25/2021
FDA clears new indication, formulation for Astellas’ Myrbetriq
Astellas is bringing forward a new treatment option for children impacted by neurogenic detrusor overactivity, a bladder dysfunction related to neurological impairment. - 3/25/2021
Xiromed launches generic Prilosec
Prilosec delayed-release capsules and its generics had a market value of $104.5 million for the 12-month period ended January 2021, according to IQVIA. - 3/24/2021
Aetna Better Health of California taps Verne Brizendine as CEO
Verne Brizendine will be responsible for the health plan’s operations and strategy to help members achieve better health outcomes. - 3/24/2021
McKesson approved as QCDR for 2021 CMS merit-based incentive payment system
CMS approved all eight of the oncology-specific custom QCDR measures developed by The US Oncology Network and submitted as part of McKesson’s 2021 application. - 3/23/2021
NCPA releases reports reflecting on COVID-19, advocacy efforts in 2020
With two new reports, the National Community Pharmacists Association is reflecting on its extensive efforts to help independent pharmacists amid the pandemic, as well as its advocacy efforts on behalf of independent community pharmacists.